Registry Strategy Boosts Diverse Parkinsonism Trial Enrollment

A new registry-based approach improves research participation rates for diverse patients at a New York City facility.

Updated on Oct. 27, 2026 in Alzheimer’s

Isometric editorial illustration of microscope slides and a geometric neuron model on a sterile laboratory surface, representing clinical research data.
Researchers at the James J Peters Veterans Affairs Medical Center in New York City increased clinical trial diversity using a registry-based strategy. AI Illustration. Upload story photo >

Live Poll

Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?

Researchers at the James J Peters Veterans Affairs Medical Center implemented a registry-based strategy to improve diverse enrollment in parkinsonism clinical trials. Published on September 11, 2026, the study found the initiative achieved equitable research participation rates among Black, Hispanic, and White patients.

Why it matters

The approach was designed to reduce selection bias in clinical research, ensuring that trial cohorts better reflect the racial and ethnic diversity of the broader patient population. By addressing barriers to entry, the model aims to improve the quality and applicability of neurological study findings.

The study cohort included 192 patients with a median age of 76, of which 96.4% were men. Findings showed 29.7% of the cohort suffered from severe parkinsonism, while researchers successfully invited 87.0% of all eligible patients to join the CANPARK study.

The players

James J Peters Veterans Affairs Medical Center

This facility is a major health provider in New York City that serves veterans and supports various clinical research initiatives.

American Parkinson Disease Association

This national organization provides support, education, and funding for research dedicated to improving the lives of those affected by Parkinson disease.

Department of Veterans Affairs

This federal agency operates the national healthcare system for veterans and provides significant funding for medical research programs.

The details

Investigators used a real-time Standard of Care Registry to track demographic and clinical data for patients at the James J Peters Veterans Affairs Medical Center. To boost participation, the team employed flexible protocols, bilingual staff, transportation support, and coordinated research procedures with existing clinical appointments.

Timeline

  1. The study data collection period began in December 2022.

  2. The study data collection period concluded in June 2024.

  3. Study findings were published on September 11, 2026.

The Big Picture

This effort follows the protocol established by the CANPARK study to address long-standing gaps in clinical trial representation. The findings demonstrate a scalable model for improving diversity in neurological research.

The implementation of coordinated, inclusive research protocols can reduce barriers to accessing advanced clinical treatments for patients with parkinsonism. By integrating study procedures with routine clinic visits, patients may find it easier to participate in medical trials without extra travel or scheduling burdens.

The takeaway

Proactive efforts to remove logistical barriers are essential for achieving representative clinical research outcomes. Researchers can significantly boost participation by aligning study requirements with the practical needs and schedules of their patient populations.

Further reading

Learn more about local clinical research efforts on the New York City Alzheimer’s section.

Source note: This article includes information reported by Neurology Advisor.

Live Poll

Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?